Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 10/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.68 |
| ▸ | POLB | P06746 | 6/20 | 0.68 |
| ▸ | MEN1 | O00255 | 6/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.68 |
| ▸ | RAB9A | P51151 | 4/20 | 0.68 |
| ▸ | BCHE | P06276 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | HTT | P42858 | 3/20 | 0.68 |
| ▸ | BLM | P54132 | 3/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.68 |
| ▸ | THRB | P10828 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.68 |
| ▸ | RECQL | P46063 | 2/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.60 |
| ▸ | MLNR | O43193 | 1/20 | 0.60 |
| ▸ | SYNJ1 | O43426 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30530887 | 0.90 | ACHE (0.68) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| SCHEMBL14007198 | 0.89 | ACHE (0.74) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| Trifluoromethanesulfonic Acid SCHEMBL4878919 | 0.88 | ACHE (0.55) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| Trifluoromethanesulfonic Acid SCHEMBL4878927 | 0.88 | ACHE (0.55) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| SCHEMBL30530876 | 0.86 | ACHE (0.64) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| SCHEMBL14007205 | 0.83 | AR (0.56) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| SCHEMBL5675231 | 0.82 | ACHE (0.97) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| SCHEMBL5675236 | 0.82 | ACHE (0.97) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| SCHEMBL14007211 | 0.82 | ACHE (0.50) | ACHEKMT2APOLBMEN1SMN1; SMN2 | |
| SCHEMBL14007200 | 0.82 | ACHE (0.61) | ACHEKMT2APOLBMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080281105-A1 | Novel Quinolinium Salts and Derivatives | IMMUSOL INCORPORATED (US) | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080281105-A1 | Novel Quinolinium Salts and Derivatives | NQO2, MCL1, KRAS | ACHE 3641/4885KMT2A 944/4885POLB 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.